Journal
RHEUMATOLOGY
Volume 49, Issue 11, Pages 2217-2219Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq249a
Keywords
Rheumatoid arthritis; British Society for Rheumatology; Guidelines; Anti-TNF therapies; Drug safety; Adverse event; Infliximab; Etanercept; Adalimumab